James Oujiri, MD
Clinical Cardiac Electrophysiology · Milwaukee, WINPI 1134187412
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (39.3%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 13 manufacturers reported payments, led by Atricure, Inc. at 46.0% of the total. Reporting peaked in 2024 at $6,522 and has fallen 90.2% since, to $641 in 2025.
Across 98 payments — averaging $176.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Atricure, Inc.$8K
- Boston Scientific$6K
- Medtronic$3K
- Abbott$159
- Novo Nordisk$86
- Cardiva Medical, Inc.$77
- plus $208 from 7 others
Across 43 payments — averaging $1636.54 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Abbott$70K
What the payments were for
- Consulting fees$6,80039%
- Speaking & faculty fees$2,00012%
- Travel & lodging$4,61327%
- Food & beverage$3,87522%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Atricure, Inc. | 18 | $7,946 |
| Boston Scientific | 41 | $6,238 |
| Medtronic(2 entities) | 19 | $2,573 |
| Abbott | 1 | $159 |
| Novo Nordisk | 4 | $86 |
| Cardiva Medical, Inc. | 4 | $77 |
| Heartflow, Inc. | 3 | $58 |
| Johnson & Johnson | 2 | $41 |
| E.r. Squibb & Sons, L.L.C. | 2 | $39 |
| Pfizer | 1 | $20 |
| Bayer | 1 | $19 |
| Teleflex LLC | 1 | $16 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ATRICLIP LAA EXCLUSION SYSTEM$7,353
- SYNERGY ABLATION SYSTEM$5,015
- ATRICURE CRYOICE CRYOABLATION SYSTEM (CRYO2)$4,800
- EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX$2,506
- WATCHMAN Access System$2,127
- Micra$1,361
- WATCHMAN FLX$271
- AVEIR$159
- Farapulse$137
- ARCTIC FRONT ADVANCE$135
- Watchman$109
- ATRICURE SYNERGY ABLATION SYSTEM$106
- ATRICURE ATRICLIP LAA EXCLUSION$106
How this compares
$17,288 in reported general payments places this provider in the 60th percentile of 78 clinical cardiac electrophysiology providers in Wisconsin.
See all clinical cardiac electrophysiology providers in Wisconsin →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 635 | $784,402 |
| XareltoRivaroxaban | 98 | $133,993 |
| MultaqDronedarone Hcl | 32 | $43,009 |
| Dofetilide | 116 | $19,762 |
| Metoprolol Succinate | 562 | $9,225 |
| Flecainide Acetate | 171 | $7,776 |
| Mexiletine Hcl | 23 | $3,746 |
| Amiodarone Hcl | 261 | $3,213 |
| SotalolSotalol Hcl | 110 | $2,632 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 63 | $1,098 |
| Warfarin Sodium | 77 | $651 |
| ClopidogrelClopidogrel Bisulfate | 80 | $618 |
| Carvedilol | 38 | $441 |
| Mupirocin | 34 | $339 |
| Metoprolol Tartrate | 42 | $270 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $20 | $784,402635 claims |
| Johnson & JohnsonXarelto | $41 | $133,99398 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 78 clinical cardiac electrophysiology providers in Wisconsin.
Other clinical cardiac electrophysiology in Milwaukee
- Imran NiaziMilwaukee$1M
- Jodi ZilinskiMilwaukee$173K
- Marcie BergerMilwaukee$67K
- Mohammad MortadaMilwaukee$65K
- Andy KieuMilwaukee$62K
- Hannah WeyMilwaukee$48K
- Varun GargMilwaukee$43K
- Jasbir SraMilwaukee$38K
- Ahmed ElawadMilwaukee$19K
- John BirchakMilwaukee$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.